News from quadrant biosciences inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 16, 2022, 13:55 ET Patent Awarded for Saliva-Based Test to Help Diagnose Concussion and Predict Duration of Symptoms

Quadrant Biosciences announced today that the U.S. Patent and Trademark Office (USPTO) has awarded the company and two of its academic partners, the...

May 31, 2022, 19:19 ET Dr. Funda Suer Joins Quadrant Biosciences as EVP of Clinical Diagnostics and CLIA Laboratory Director

Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice...

Apr 07, 2022, 16:12 ET Dana Dean Joins Quadrant Biosciences as VP of Public Relations

Quadrant Biosciences Inc., a developer of novel molecular diagnostic tools, announced that Dana Dean has joined the company as Vice President of...

Mar 09, 2022, 11:54 ET New Study Shows Relationship of GI-Related Saliva RNAs and Autism

Saliva may hold the key to understanding and ultimately treating gastrointestinal (GI) disturbance in children with autism spectrum disorder (ASD). A ...

Feb 28, 2022, 13:30 ET Patent Issued for Multiomic Approach to Autism Spectrum Disorder Diagnosis

Quadrant Biosciences Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued the company and its partners, the...

Sep 29, 2021, 13:17 ET New Research Supports the Use of Saliva Biomarkers for Sports-Related Concussion

Salivary microRNA (miRNA) molecules continue to show great promise as biomarkers to accurately diagnose sports related concussion (SRC), as recently...

Jul 15, 2021, 12:34 ET Saliva RNA Biomarkers Show Promise to Predict Concussion Duration and Detect Symptom Recovery

Saliva biomarkers show promise for tracking recovery from concussion injuries, and for predicting which patients will experience prolonged symptoms,...

Jun 03, 2021, 15:35 ET Molecules in Saliva May Hold the Key to Tracking Improvements in Autism

Molecules in the saliva may hold promise as a means to track the effectiveness of therapeutic interventions in children with autism spectrum disorder ...

Apr 22, 2021, 15:39 ET Autism Biomarkers Could Save Billions in Healthcare Costs According to Recent Study

The use of accurate biomarkers for detecting autism spectrum disorder (ASD) could result in saving billions of dollars in healthcare costs, according ...

Apr 19, 2021, 15:27 ET Quadrant Biosciences Receives Breakthrough Device Designation for Novel Autism Saliva Test

Quadrant Biosciences Inc., a developer of novel molecular diagnostic tools, has been granted a Breakthrough Device designation by the Center of...

Sep 23, 2020, 16:52 ET Quadrant Biosciences Receives FDA Emergency Authorization for New COVID-19 Saliva Test

Quadrant Biosciences Inc., a developer of epigenetic diagnostic tools, announced today that it has received an Emergency Use Authorization (EUA) from ...

Dec 04, 2019, 13:36 ET Quadrant Biosciences Launches First Ever Epigenetic Saliva Test for Autism

Quadrant Biosciences Inc., a developer of novel diagnostic solutions, announced the release of Clarifi ASD™, the first ever epigenetic test for...

Jul 01, 2019, 11:45 ET New Research shows link between Parkinson's disease and the microbiome

A simple saliva swab may provide an accurate way of detecting Parkinson's disease in its earliest stages, according to a study just published in the...

Jun 19, 2019, 15:35 ET Quadrant Biosciences Takes Next Step in the Detection of Autism

Quadrant Biosciences Inc., a developer of epigenetic diagnostic technologies, has been awarded a $330,000 grant from the National Institutes of...

May 07, 2019, 13:15 ET Quadrant Biosciences Recognized as New York Technology Business of the Year

Quadrant Biosciences Inc. has been awarded the Technology Business of the Year by the New York State Small Business Development Center (SBDC). The...

Apr 09, 2019, 11:49 ET Study finds correlation between specific epigenetic molecules and autism traits

Scientists have discovered certain molecules in the saliva that not only differentiate children with autism spectrum disorder (ASD), but appear to...

Aug 10, 2018, 16:15 ET US All Star Federation Cheer Organization Partners with Quadrant Biosciences to Offer Brain Health Assessments

The US All Star Federation ("USASF"), a nonprofit corporation established to make All Star Cheer and Dance teams a safer sport, has selected Quadrant ...

Aug 08, 2018, 15:31 ET Quadrant Biosciences Partners with Leading Edge Genomic Testing Company Admera Health

Quadrant Biosciences Inc., an emerging life science company based in Syracuse, New York, is pleased to announce its strategic partnership with Admera ...

Aug 01, 2018, 16:30 ET ClearEdge Wins 2018 Sports Medicine Technology Award

Quadrant Biosciences Inc., an emerging life science company based in Syracuse, New York, announced that its ClearEdge Brain Health Toolkit was named...

Jul 19, 2018, 16:15 ET Researchers Discover Key Link to Understanding Sleep Disorders

Researchers have discovered a key link to potentially understanding sleep disorders in children, according to a study just published in the journal...

Jun 04, 2018, 12:54 ET Quadrant Biosciences Inc. and ChoiceOne/MedSpring Urgent Care Enter Partnership to Offer Unique Brain Health Assessments

Quadrant Biosciences Inc. ("Quadrant Biosciences"), a Life Science company focused on functional assessment tools and epigenetic biomarkers for brain ...

Apr 24, 2018, 02:15 ET Wall Street Veteran Peter Cohen joins Quadrant Biosciences Board of Directors

Quadrant Biosciences Inc., a Syracuse, New York-based Life Science company, announced today that Wall Street veteran Peter Cohen will be joining its...

Apr 10, 2018, 04:05 ET Quadrant Biosciences Enters into Licensing Agreements with SUNY Upstate and Penn State for Commercialization of Novel Epigenetic Biomarkers

Quadrant Biosciences Inc., a Syracuse, New York-based Life Science company, announced today the execution of three licensing agreements with SUNY...

Mar 14, 2018, 02:45 ET HOF Players Foundation and Quadrant Biosciences Partner to Address Former Football Players' Health Concerns

HOF Players Foundation, Inc. ("HOF Players Foundation"), established by members of the Pro Football Hall of Fame, and Quadrant Biosciences Inc....

Nov 22, 2017, 13:00 ET Salivary microRNA may predict duration and nature of concussion symptoms among children

Small molecules in saliva may hold the key to predicting the type and duration of concussion symptoms, according to a study just published in the...